195rar

In a study published in , scientists investigated a protein called SYK (Spleen Tyrosine Kinase). They knew SYK was present in blood cancers but weren't sure exactly how it contributed to the disease. They discovered that SYK acts as a "partner in crime" with another protein called FLT3 , which is frequently mutated in leukemia patients. The 195RAR Mutation

This tiny change—the mutation—acted like changing the shape of a key so it no longer fits a lock. What the Story Revealed

In scientific research, "195RAR" refers to a specific genetic mutation used to study how certain proteins interact within the body, particularly in the context of cancer development. 195rar

Highly active SYK can help cancer cells ignore standard treatments meant to kill FLT3-driven leukemia.

SYK must physically touch FLT3 to activate it. In a study published in , scientists investigated

When the researchers used the SYK mutant with the change, the protein could no longer bind to FLT3. This was a "Eureka" moment because it proved:

The story of is a technical one, centered on the SYK protein and its role in Acute Myeloid Leukemia (AML) . Researchers used this mutation to unlock a secret about how cancer cells survive and resist treatment. The Mystery of the SYK Protein SYK must physically touch FLT3 to activate it

SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia